Latest filings (excl ownership)
15-12G
Securities registration termination
2 May 24
8-K
Completion of Acquisition or Disposition of Assets
2 May 24
8-K
Amendments to Articles of Incorporation or Bylaws
2 May 24
DEFM14C
Information related to merger
11 Apr 24
PREM14C
Preliminary information related to merger
1 Apr 24
10-K
2023 FY
Annual report
20 Mar 24
8-K
QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
7 Feb 24
8-K
Other Events
16 Jan 24
8-K
Receives $2 Million Pre-Closing Collaboration and Option Fee
14 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Unregistered Sales of Equity Securities
29 Sep 23
8-K
QSAM Biosciences Provides Update to Shareholders on Phase 1 Progress and Preliminary Clinical Data
16 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
Unregistered Sales of Equity Securities
23 Jun 23
10-Q
2023 Q1
Quarterly report
15 May 23
8-K
Changes in Registrant's Certifying Accountant
12 May 23
8-K
Regulation FD Disclosure
11 Apr 23
8-K
Unregistered Sales of Equity Securities
4 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
8-K
Regulation FD Disclosure
22 Mar 23
8-K
Regulation FD Disclosure
25 Jan 23
8-K
QSAM Biosciences Provides 2022 Update and 2023 Milestones to Shareholders
10 Jan 23
8-K
Unregistered Sales of Equity Securities
18 Nov 22
8-K
QSAM Biosciences Reports Third Quarter 2022 Financial Results and Provides Corporate Update
15 Nov 22
10-Q
2022 Q3
Quarterly report
14 Nov 22
D
$3.50 mm in equity / options, sold $925.00 k, 3 investors
6 Oct 22
8-K
Unregistered Sales of Equity Securities
6 Oct 22
8-K
QSAM Biosciences Reports Second Quarter 2022 Financial Results and Provides Corporate Update
16 Aug 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
8-K
QSAM Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
17 May 22
RW
Registration withdrawal request
16 May 22
10-Q
2022 Q1
Quarterly report
16 May 22
S-1/A
IPO registration (amended)
4 Apr 22
S-1/A
IPO registration (amended)
1 Apr 22
CERT
Certification of approval for exchange listing
29 Mar 22
8-A12B
Registration of securities on exchange
28 Mar 22
S-1/A
IPO registration (amended)
23 Mar 22
S-1/A
IPO registration (amended)
10 Mar 22
8-K
Amendments to Articles of Incorporation or Bylaws
9 Mar 22
8-K
Departure of Directors or Certain Officers
4 Mar 22
Latest ownership filings
SC 13G/A
Strategic Planning Assets Ltd
2 May 24
SC 13G/A
GSB Holdings, Inc.
2 May 24
SC 13D/A
Checkmate Strategic Capital 2, LLC
2 May 24
4
C Richard Piazza
2 May 24
4
Douglas R Baum
2 May 24
4
Christopher M. Nelson
2 May 24
4
Jr. Charles J Link
2 May 24
4
Adriann Sax
2 May 24
4
Adam King
2 May 24
SC 13D/A
Checkmate Strategic Capital 2, LLC
20 Feb 24
5
Charles Thomas Paschall
20 Feb 24
SC 13G/A
Strategic Planning Assets Ltd
20 Feb 24
SC 13G/A
GSB Holdings, Inc.
15 Feb 24
4/A
Douglas R Baum
14 Feb 24
4/A
Christopher M. Nelson
14 Feb 24
4/A
Jr. Charles J Link
14 Feb 24
4
Douglas R Baum
13 Feb 24
4
Christopher M. Nelson
13 Feb 24
4
Adam King
29 Jun 23
3
Adam King
29 Jun 23
4
Adriann Sax
23 Jun 23
4
Jr. Charles J Link
23 Jun 23
4
Douglas R Baum
23 Jun 23
4
C Richard Piazza
23 Jun 23
4
Christopher M. Nelson
23 Jun 23
SC 13G/A
GSB Holdings, Inc.
14 Feb 23
4
Douglas R Baum
4 Jan 23
4
Christopher M. Nelson
4 Jan 23
4
C Richard Piazza
4 Jan 23
4
Jr. Charles J Link
8 Mar 22
4
Douglas R Baum
7 Mar 22
4
Christopher M. Nelson
7 Mar 22
4
C Richard Piazza
7 Mar 22
4
Adriann Sax
7 Mar 22
4
Adriann Sax
17 Feb 22
3
Adriann Sax
17 Feb 22
5
C Richard Piazza
15 Feb 22
5
Douglas R Baum
15 Feb 22
5
David Charles Link
15 Feb 22
5
Christopher M. Nelson
14 Feb 22